The latest c-level appointments in drug discovery

New appointments

Despite December usually being a slower time for recruitment, there has been a high number of senior moves within the drug discovery sector over the last three months.

Shorla Oncology has appointed Rayna Sethi Herman as Chief Commercial Officer. Herman leaves a role as CCO at EVERSANA, and brings more than 30 years of expertise in commercialisation.

Veranova has announced the appointment of Jose Ibietatorremendia as the company’s SVP, General Counsel, and Secretary. Ibietatorremendia has over 20 years of in-house legal leadership experience.

Dr Martin Gershon, former Harvard and Columbia-trained neuroscientist, oncologist, immunologist, FDA attorney, and Ivy League professor, has joined Pepper Bio as a senior advisor.

Sphere Fluidics has welcomed Dr Graeme Daniels as its new Vice President of Sales and Marketing, bringing over 20 years of experience in the life sciences and biotechnology industries.

Cancer Research Horizons has made two additions to its board of directors.

Annalisa Jenkins brings over 25 years of life-science leadership expertise, while Christoph Lengauer, cofounder of Curie.Bio, takes up the role of inaugural chair of the Therapeutic Innovation board.

Totus Medicines has named Dr Nassim Usman as its new President & Chief Executive Officer. Dr Usman moves from Catalyst Biosciences (now Gyre Therapeutics) and has an extensive background in C-Suite management.

Robert Lisicki and Kiran Nistala have joined Zura Bio as President and Chief Operating Officer, and Executive Vice President Development and Chief Medical Officer, respectively. They have both worked on or led in the development of multiple drugs within the auto-immune therapeutic area.

X-Chem’s Karen Lackey, previously Chief Scientific Officer, has become Chief Executive Officer of the company, bringing extensive drug discovery experience in both pharma and service organisations.

Cure Ventures has added two partners to its leadership team – Jeff Jonas, previously the CEO of Sage Therapeutics, and Al Robichaud, former Chief Scientific Officer at Sage.

TechBio Cytomos has appointed Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser.

Peter Crossley has moved to Cellular Origins as Chief Operating Officer, bringing 27 years’ experience in novel technology and product development, most recently as interim CTO at Depixus.

CN Bio has added Joseph Parisi as US Director of Sales. Parisi moved from Phenomix (acquired by Bruker Corporation in 2023), where he was Director of Sales for US West and led the proteomics sales team.

Dr Daniel Turner is the new Chief Scientific Officer at Enhanc3D Genomics. Turner has over 20 years of senior leadership, moving from Oxford Nanopore Technologies, where he held roles including Senior Vice President.

Phenomenex has announced Dr Kaveh Kahen as its new President. Dr Kahen began his career at SCIEX, held various leadership roles at PerkinElmer, and most recently served as CEO at Advion Interchim Scientific.

QuantHealth has appointed its first Chief Medical Officer, Dr Adam Petrich, and its first Chief Financial Officer, Adam Goldberger. Dr Petrich has spent the last ten years in oncology drug development, including at Daiichi-Sankyo and AbbVie. Goldenberg has come from roles as Chief Business Officer at RenalSense and CFO/Group Executive at MedHealth.

By DIANA SPENCER, Senior Digital Content Editor, DDW

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free